Elite Pharma Technology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Elite Pharma Technology - overview
Established
2010
Location
Shanghai, -, China
Primary Industry
Pharmaceuticals
About
Based in Shanghai, China, and established in 2010, Elite Pharma Technology is a pharmaceutical company that focuses on developing pharmaceutical formulation technology. Its products have acquired FDA marketing authorization. The core founding team has over 20 years of work experience in pharmaceutical research and development, process development, drug production, and drug registration. In May 2020, the company closed a series A funding.
The company is committed to the development and innovation of pharmaceutical processes and drug delivery technologies, which has established a series of oral complex slow and controlled release technology platforms. The research and development varieties are mainly in the fields of cardiovascular, endocrine, autoimmune, and other chronic diseases. The company generates revenue by providing drug formulation technology research and development services.
Current Investors
Suzhou Xiangtang Venture Investment, Kaitai Capital, South China Venture Capital
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.elitepharmatech.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.